Although this entitle suggests more of some feast, the actual existence however engages in a technological conversation. Well, the University of Alberta has amazingly devised a new chip which can seamlessly execute the same genetic tests as most advanced laboratories. Termed ‘Domino’, the promising technology thus endeavors to open new doors for generic tests with utmost accuracy.
The development, however, benefits from a miniscule plastic chip and distinctive nanotechnology that may help determine whether an individual has diseases or is resistant to cancer drugs. In fact, the efficient chip can even shed some light on the possible infectious diseases in a herd of cattle.
Proposed by a U and A research team, the new chip basically aims at replacing expensive treatment methods or equipments that also fall short of rendering optimum, reliable results. But what exactly makes Domino stand distinguished in its precise term? If go by what developers from the University of Alberta have to state, the deeply embedded polymerase chain reaction technology enables the midget-sized chip to amplify and identify targeted sequences of DNA.
The diminutive structure, whereas, does not compromise on the efficacy of its mechanism but rather fits comfortable on a plastic chip the size of two postage stamps. There are 20 gel posts inside the tiny framework of the chip, whereby each the dimension of a pinhead – capable of determining the sequences of DNA with just a single drop of blood. Indeed a breakthrough innovation as far as a medical field is concerned!
Furthermore, the technology enables personalized medicine and helps detect diseases in patients at the right time, right in their doctor’s office. But, the development’s affordability and portability may be considered as its two key selling points. The rugged yet super compact Domino technology, however, is yet to witness its worldwide availability, beginning with markets first in Alberta.